课题基金 / 基金详情

项目摘要

项目成果

Donna M Peters的其他基金

相似基金

相关文献

中文摘要
翻译
这是R 01的新应用程序。该基金的长期目标是鉴定整合素信号通路 这些机制可以用作控制和降低眼内压的治疗靶点。哥伦比亚人, 其导致视网膜神经节细胞的不可逆损失,影响全世界约6700万人。他们 通常与眼内压(IOP)水平升高有关,这是由于眼内水减少所致。 从小梁网(TM)流出的体液。尽管已知许多生理因素 管制资金外流机制,这是已成为一个重要的管制机制的关键因素之一, 流出设施是TM的收缩特性。目前尚不清楚是什么分子事件 调节TM的收缩性。我们实验室的研究表明, 来自细胞外基质(ECM)及其受体(整合素)的生物活性片段可用于调节 培养的眼前节中TM的收缩性和增加流出设施。特别是我们有 表明来自纤连蛋白的一个称为HepII结构域的生物活性结构域激活了<$4 <$1整合素信号传导, 在培养的TM细胞中降低细胞收缩性的途径。我们的初步数据强烈支持 假设在TM中调节细胞收缩性整联蛋白信号通路的操纵可以 用于调节流出设施。本研究的目的是确定可能的方法,目标整合素 在TM的信号通路,以增加流出设施。为此,我们提出三种方法, 激活培养的眼前节中的<$4 <$1信号通路。首先,使用慢病毒载体来表达一种 TM中的mini-HepII基因。第二,在TM中过表达组成型激活的整合素亚基。 第三,表达来自整合素4亚基或整合素结合蛋白桩蛋白的胞质结构域的肽 其破坏细胞粘附并降低细胞收缩性。本申请中提出的研究将不 这只会增强我们对整合素信号传导在TM中的作用的理解,但它将确定新的靶向方法, TM中的细胞收缩性。
英文摘要
This is a new application for a R01. The long-term objective of this grant is to identify integrin signaling mechanisms that can be used as therapeutic targets to control and lower intraocular pressure. The glaucomas, which lead to irreversible loss of retinal ganglion cells, affect approximately 67 million people worldwide. They are commonly associated with elevated levels of intraocular pressure (IOP) due to a reduction in aqueous humor outflow from the trabecular meshwork (TM). Although a number of physiological factors are known to regulate outflow facility, one of the key factors that have emerged as an important regulatory mechanism for outflow facility is the contractile properties of the TM. At the present, it is unclear what molecular events regulate contractility in the TM. Studies from our laboratory have shown that the signaling properties of bioactive fragments from the extracellular matrix (ECM) and their receptors (integrins) can be used to regulate the contractility of the TM and increase outflow facility in cultured anterior segments. In particular we have shown that a bioactive domain from fibronectin called the HepII domain activates a ¿4¿1 integrin signaling pathway that decreases cell contractility in cultured TM cells. Our preliminary data strongly supports the hypothesis that manipulation of integrin signaling pathways in the TM that modify cellular contractility can be used to regulate outflow facility. The objective of this research is to identify possible ways to target integrin signaling pathways in the TM in order to increase outflow facility. To this end, we propose three approaches to activate the ¿4¿1 signaling pathway in cultured anterior segments. First, use lentiviral vectors to express a mini-HepII gene in the TM. Second, over express a constitutively activated ¿4 integrin subunit in the TM. Third, express peptides from the cytoplasmic domain of the ¿4-subunit or the integrin binding protein, paxillin which disrupt cell adhesion and decrease cell contractility. The studies proposed in this application will not only enhance our understanding of the role of integrin signaling in the TM, but it will identify new ways to target cell contractility in the TM.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
NFAT and fibrosis in the trabecular meshwork
  • 批准号:
    10630268
  • 项目类别:
  • 资助金额:
    $41.6万
  • 财政年份:
    2022
  • 负责人:
    Donna M Peters
  • 依托单位:
NFAT and fibrosis in the trabecular meshwork
  • 批准号:
    10436632
  • 项目类别:
  • 资助金额:
    $42.0万
  • 财政年份:
    2022
  • 负责人:
    Donna M Peters
  • 依托单位:
Targeting the Anterior Segment with Homing Peptides from Phage Display
  • 批准号:
    8487758
  • 项目类别:
  • 资助金额:
    $22.58万
  • 财政年份:
    2013
  • 负责人:
    Donna M Peters
  • 依托单位:
Targeting the Anterior Segment with Homing Peptides from Phage Display
  • 批准号:
    8651496
  • 项目类别:
  • 资助金额:
    $18.44万
  • 财政年份:
    2013
  • 负责人:
    Donna M Peters
  • 依托单位:
海外基金